Good afternoon, and welcome to IGM Biosciences, Inc. 2024 Annual Meeting of Stockholders. Please note that this event is being webcast. I would now like to introduce Fred Schwarzer, the company's Chief Executive Officer, President, and Director. Mr. Schwarzer, please go ahead. Welcome, everyone, and thank you for joining our 2024 Annual Meeting of Stockholders. The principal purpose of this meeting is to seek stockholder approval of certain proposals. We will begin with the formal business portion, during which we will address the matters described in our 2024 proxy statement for which approval is sought, vote on these proposals, and announce preliminary voting results. At this time, I'd like to introduce the other members of our board of directors who are participating in the meeting today. The directors include Dr. Felix Baker, Dr. Kathleen Behrens, Dr. Julie Hambleton, Michael Lee, Dr. William Strohl, Dr. Elizabeth H.Z. Thompson, Christina Teng Topsøe. We also have with us Tricia Siegel of Deloitte & Touche, LLP, our independent registered public accounting firm, as well as Jennifer Knapp of Wilson Sonsini Goodrich & Rosati, P.C., our outside legal counsel. We have appointed Victor Latessa to act as the Inspector of Election today. He has executed an oath of office to carry out his duties with strict impartiality and to the best of his ability, and he will examine and tabulate the proxies and ballots at this meeting. With introductions concluded, I would now like to turn the meeting over to Misbah Tahir, our Chief Financial Officer, Secretary, and Treasurer, who will lead the formal business of the meeting and also act as Secretary of the meeting. Thank you, Fred. As Fred noted, we will begin with the formal business portion of our meeting. Our board of directors has fixed the close of business on April 15, 2024, as the record date for determining the stockholders entitled to vote at this meeting. I have an affidavit of distribution from Broadridge Financial Solutions, confirming that proxy materials related to this meeting were mailed to stockholders of record, determined as of the close of business on the record date, on or about April 26th, 2024. A complete list of stockholders entitled to vote at this meeting was made available for examination during the 10 days leading up to this meeting. Each holder of common stock is entitled to one vote for each share of common stock held at record at the close of business on the record date. Holders are not entitled to vote shares of non-voting common stock on any proposals. Mr. Latessa reports that the holders of a majority of the voting power of our common stock outstanding, as of the record date, are present at the meeting, either in person, virtually, or by proxy, which constitutes a quorum. Therefore, today's meeting is duly convened and ready to transact business. We'll now proceed with the formal business of the meeting. It is 8:03 A.M., and the polls are open. If any stockholders have not yet voted or wish to change their vote, please click on the voting button in the web portal and follow the instructions. If you have already sent in a proxy or voted via the telephone or internet and do not wish to change their vote, no further action is needed. There are four proposals to be considered and voted upon by our stockholders today. Each of these proposals is more fully described in our proxy statement, filed with the Securities and Exchange Commission on April 26, 2024. The first proposal is to elect three Class Two directors, M. Kathleen Behrens, Ph.D., Elizabeth H.Z. Thompson, Ph.D., and Christina Teng Topsøe, to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified. No other director nominees have been properly submitted pursuant to our bylaws or the rules of the Securities and Exchange Commission, so no other nominations are being considered. Each of the three director nominees is currently serving on our board, and our board of directors recommends a vote for all of these director nominees. The second proposal is to ratify the appointment of Deloitte & Touche, LLP, as our independent registered public accounting firm for our fiscal year ending December 31, 2024. Our board of directors recommends a vote for the ratification of the appointment of Deloitte & Touche, LLP, as our independent public accounting firm for our fiscal year ending December 31, 2024. The third proposal is to approve an amendment to our amended and restated certificate of incorporation to limit the liability of certain officers as permitted by Delaware law. Our board of directors recommends a vote for the approval of an amendment of our amended and restated certificate of incorporation to limit the liability of certain officers as permitted by Delaware law. The fourth proposal is to approve a stock option exchange program for employees, excluding the company's Chief Executive Officer and non-employee directors, as described in our proxy statement. Our Board of Directors recommends a vote for the approval of a stock option exchange program for employees, excluding the company's chief executive, executive officer, and non-employee directors, as described in our proxy statement. The polls are still open, and we will vote on these proposals. Voting today is by proxy and online ballot. As previously mentioned, if you already submitted a proxy or voted via the telephone or internet, and do not wish to change your vote, no further action is needed at this time. If you have not yet voted or wish to change your vote, you may do so now by clicking on the voting button in the web portal and following the instructions. If you have not yet submitted a proxy or electronic ballot, you must submit your electronic ballot now for your vote to be counted by the Inspector of Election. We will leave the polls open for another minute to allow anyone who chooses to vote electronically to cast their ballots now. Please note that upon the closing of the polls, no additional ballots, proxies, or votes, nor any changes or revocations will be accepted. It is now 8:08 A.M., and since everyone has had the opportunity to vote, the polls are now closed with respect to each matter to be voted on at this meeting. No additional ballots, proxies, or votes, and no exchanges or revocations will be accepted at this time. Mr. Latessa will report on the preliminary voting results. Mr. Latessa, please go ahead when you are ready. My preliminary report shows the following: regarding the first proposal, the election of Class Two directors, M. Kathleen Behrens, Ph.D., Elizabeth H.Z. Thompson, Ph.D., and Christina Teng Topsøe, received the greatest number of votes in favor of their election, with each receiving more than 90% of the votes in favor of election. Regarding the second proposal, the ratification of the appointment of Deloitte & Touche, LLP, as the company's independent public accounting firm for the fiscal year ending December 31, 2024, more than 99% of the votes were in favor of the ratification. Regarding the third proposal, to approve an amendment to the company's amended and restated certificate of incorporation to limit the liability of certain officers as permitted by Delaware law, more than 83% of the votes were in favor of the approval. Regarding the fourth proposal, to approve the stock option exchange program for employees, excluding the company's Chief Executive Officer and non-employee directors, as described in the proxy statement, more than 96% of the votes were in favor of the approval. Thank you, Mr. Latessa. Based on these preliminary voting results, a majority of the shares present in person, virtually or by proxy, have voted to elect the three Class Two directors to serve until the 2027 annual meeting of stockholders, or until their successors are duly elected and qualified. Ratify the appointment of Deloitte & Touche, LLP, as our independent registered public accounting firm for our fiscal year ending December 31, 2024. Approve an amendment to our amended and restated certificate of incorporation to limit the liability of certain officers as permitted by Delaware law, and approve a stock option exchange program for employees, excluding the company's Chief Executive Officer and non-employee directors, as described in the proxy statement. The final voting results will be set forth in a report for the Inspector of Election and will be included in the minutes of this meeting. We will also report the final voting results on a Form 8-K, which we will file with the Securities and Exchange Commission within four business days of today's date. This concludes our planned agenda today. As there is no other formal business before us, I now declare the formal business portion of the meeting adjourned. Thank you for joining us today and for your continued support of IGM. Thank you for joining today's meeting. You may now disconnect. Have a pleasant day.